Sep 26, 2023 / 12:00PM GMT
Presentation
Sep 26, 2023 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Chris Keenan
Pliant Therapeutics, Inc. - Vice President, Investor Relations and CorporateCommunications
* Bernard Coulie
Pliant Therapeutics, Inc. - President & CEO
* Ãric Lefebvre
Pliant Therapeutics, Inc. - Chief Medical Officer
* Gideon Hirschfield
University of Toronto - Lily and Terry Horner Chair in Autoimmune Liver DiseaseResearch & Investigator
=====================
Conference Call Participants
=====================
* Brian Abrahams
RBC Capital Markets - Analyst
* Yasmeen Rahimi
Piper Sandler - Analyst
* Ritu Baral
TD Cowen - Analyst
* Jeff Jones
Oppenheimer - Analyst
* Eric Joseph
JP Morgan - Analyst
* Mike Kratky
Leerink Partners - Analyst
* David Lebowitz
Citi - Analyst
* Tom Shrader
BTIG - Analyst
* Joel Beatty
Robert W Baird & Co Inc - Senior
Pliant Therapeutics Inc
(FRA:9PT)
€
10.5
0 (0%)
Market Cap: 794.88 Mil
Enterprise Value: 447.14 Mil
PE Ratio: 0
PB Ratio: 2.18
GF Score: 37/100 Pliant Therapeutics Inc INTEGRIS-PSC Interim Phase 2a Data Presentation Transcript
Sep 26, 2023 / 12:00PM GMT
Release Date Price:
€14.9
(+6.43%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot